Search Results - KeDa Yu

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer by Le-Wei Zheng, Cui-Cui Liu, Ke-Da Yu

    Published in Journal of Hematology & Oncology (2023-12-01)
    Get full text
    Article


  2. 2

    RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond by You-Peng Ding, Cui-Cui Liu, Ke-Da Yu

    Published in Experimental Hematology & Oncology (2025-04-01)
    Get full text
    Article


  3. 3

    Effect of functional genetic variants in chemokine decoy receptors on the recurrence risk of breast cancer by Dou‐Dou Li, Chen Yang, Zhi‐Ming Shao, Ke‐Da Yu

    Published in Cancer Medicine (2018-11-01)
    Get full text
    Article


  4. 4

    Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions by Yu‐Fei Chen, Ying‐ying Xu, Zhi‐Ming Shao, Ke‐Da Yu

    Published in Cancer Communications (2023-03-01)
    Get full text
    Article


  5. 5

    Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era by Xin Xiong, Xin Wang, Cui-Cui Liu, Zhi-Ming Shao, Ke-Da Yu

    Published in Biomarker Research (2024-09-01)
    Get full text
    Article


  6. 6

    Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women. by Shuang Hao, Yin Liu, Ke-Da Yu, Sheng Chen, Wen-Tao Yang, Zhi-Min Shao

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  7. 7

    Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer. by Sheng Chen, Can-Ming Chen, Ying Zhou, Ruo-Ji Zhou, Ke-Da Yu, Zhi-Ming Shao

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  8. 8

    Interaction between glutathione S‐transferase M1‐null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer by Shuang Li, Guan‐Tian Lang, Ying‐Zhou Zhang, Ke‐Da Yu, Zhi‐Ming Shao, Qiang Zhang

    Published in Cancer Medicine (2018-09-01)
    Get full text
    Article


  9. 9

    Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. by Ao-Xiang Chen, Ke-Da Yu, Lei Fan, Ji-Yu Li, Chen Yang, A-Ji Huang, Zhi-Ming Shao

    Published in PLoS Genetics (2011-09-01)
    Get full text
    Article


  10. 10

    Multiomics of HER2-low triple-negative breast cancer identifies a receptor tyrosine kinase–relevant subgroup with therapeutic prospects by Lie Chen, Cui-Cui Liu, Si-Yuan Zhu, Jing-Yu Ge, Yu-Fei Chen, Ding Ma, Zhi-Ming Shao, Ke-Da Yu

    Published in JCI Insight (2023-11-01)
    Get full text
    Article


  11. 11

    MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor–positive HER2-negative breast cancer by Yu-Wen Cai, Cui-Cui Liu, Yan-Wu Zhang, Yi-Ming Liu, Lie Chen, Xin Xiong, Zhi-Ming Shao, Ke-Da Yu

    Published in The Journal of Clinical Investigation (2025-01-01)
    Get full text
    Article


  12. 12

    Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial by Wen-Jia Zuo, Li Chen, Yu Shen, Zhong-Hua Wang, Guang-Yu Liu, Ke-Da Yu, Gen-Hong Di, Jiong Wu, Jun-Jie Li, Zhi-Ming Shao

    Published in Therapeutic Advances in Medical Oncology (2024-02-01)
    Get full text
    Article


  13. 13

    Breast cancer: pathogenesis and treatments by Xin Xiong, Le-Wei Zheng, Yu Ding, Yu-Fei Chen, Yu-Wen Cai, Lei-Ping Wang, Liang Huang, Cui-Cui Liu, Zhi-Ming Shao, Ke-Da Yu

    Published in Signal Transduction and Targeted Therapy (2025-02-01)
    Get full text
    Article


  14. 14

    A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study by Li Chen, Wen‐Ya Wu, Fei Liang, Guang‐Yu Liu, Ke‐Da Yu, Jiong Wu, Gen‐Hong Di, Lei Fan, Zhong‐Hua Wang, Jun‐Jie Li, Zhi‐Ming Shao

    Published in Cancer Communications (2025-04-01)
    Get full text
    Article


  15. 15

    Artificial intelligence-based diagnosis of breast cancer by mammography microcalcification by Qing Lin, Wei-Min Tan, Jing-Yu Ge, Yan Huang, Qin Xiao, Ying-Ying Xu, Yi-Ting Jin, Zhi-Ming Shao, Ya-Jia Gu, Bo Yan, Ke-Da Yu

    Published in Fundamental Research (2025-03-01)
    Get full text
    Article


  16. 16

    ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy. by Jian-Wei Li, Miao Mo, Ke-da Yu, Can-Ming Chen, Zhen Hu, Yi-Feng Hou, Gen-Hong Di, Jiong Wu, Zhen-Zhou Shen, Zhi-Ming Shao, Guang-Yu Liu

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  17. 17

    Combined Single‐Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination by Yi‐Ming Liu, Jing‐Yu Ge, Yu‐Fei Chen, Tong Liu, Lie Chen, Cui‐Cui Liu, Ding Ma, Yi‐Yu Chen, Yu‐Wen Cai, Ying‐Ying Xu, Zhi‐Ming Shao, Ke‐Da Yu

    Published in Advanced Science (2023-02-01)
    Get full text
    Article


  18. 18

    Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II studyResearc... by Min He, Shuang Hao, LinXiaoxi Ma, BingQiu Xiu, BenLong Yang, ZeHao Wang, JingYan Xue, YaYun Chi, Min Xiong, JiaJian Chen, XiaoYan Huang, XiYu Liu, SongYang Wu, Qin Xiao, Yan Huang, RuoHong Shui, AYong Cao, JunJie Li, GenHong Di, WenTao Yang, Xin Hu, GuangYu Liu, KeDa Yu, YiZhou Jiang, ZhongHua Wang, ZhiMing Shao, Jiong Wu

    Published in EClinicalMedicine (2024-08-01)
    Get full text
    Article


Search Tools: